---
title: "AVG: Revenue, profit, and order book grew; nuclear and medical sectors drive future outlook"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300525213.md"
description: "Revenue and profitability improved year-over-year, driven by strong performance in engineering and new nuclear contracts. Medical imaging investments are progressing, with regulatory milestones achieved. Balance sheet remains robust, supporting continued dividend growth and future expansion.Original document: Avingtrans plc [AVG] Slides Release — Sep. 30 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-09-30T06:24:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300525213.md)
  - [en](https://longbridge.com/en/news/300525213.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300525213.md)
generator: "portal-rs"
---

# AVG: Revenue, profit, and order book grew; nuclear and medical sectors drive future outlook

Revenue and profitability improved year-over-year, driven by strong performance in engineering and new nuclear contracts. Medical imaging investments are progressing, with regulatory milestones achieved. Balance sheet remains robust, supporting continued dividend growth and future expansion.

Original document: Avingtrans plc \[AVG\] Slides Release — Sep. 30 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

## Related News & Research

- [AJB Investment Fund II acquires USD 21,594 Jewett-Cameron Trading common shares](https://longbridge.com/en/news/300831535.md)
- [Xi Zhang Secures Board Control Rights at GOWell Energy Technology with 74% Stake](https://longbridge.com/en/news/300833073.md)
- [Avalanche: KSD builds connectivity for South Korea's onchain securities framework - Feb 2027](https://longbridge.com/en/news/300832601.md)
- [Resonant Clinical Solutions amplía su negocio global de equipos y accesorios con la adquisición de Labfish](https://longbridge.com/en/news/300832921.md)
- [XtalPi advances hair loss drug program into IND-enabling studies](https://longbridge.com/en/news/300831965.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**